Actively Recruiting

Age: 18Years - 65Years
All Genders
ID07578675

Construction of Abnormal Projection Regions of Cognitive Neural Networks in Patients With Anemia Using Functional Near-Infrared Spectroscopy (fNIRS)

Led by Institute of Hematology & Blood Diseases Hospital, China · Updated on 2026-05-11

323

Participants Needed

1

Research Sites

39 weeks

Total Duration

On this page

Sponsors

I

Institute of Hematology & Blood Diseases Hospital, China

Lead Sponsor

T

Tianjin University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Anemia is a widespread health issue linked to problems in brain cognitive neural networks, which are important for memory, learning, processing speed, and executive function. These cognitive impairments can reduce daily functioning and increase risks of falls and depression. Researchers are studying how anemia affects these brain networks to help detect cognitive problems early and improve treatment strategies. This research uses functional near-infrared spectroscopy (fNIRS) to monitor changes in oxygenated and deoxygenated hemoglobin in the brain, reflecting neural activity. The study aims to identify brain regions affected by anemia and visualize changes in connectivity through heatmaps and arc-based mapping. These insights will support personalized approaches to manage cognitive impairment in anemia patients. Participants diagnosed with anemia and hospitalized for the first time will be assessed within 48 hours of admission. Evaluations include measurements of hemoglobin concentrations using fNIRS and cognitive function tests. Additional assessments will examine anxiety, depression, sleep quality, physical fatigue, and appetite. The study will help understand brain function changes related to anemia and guide clinical care to improve quality of life.

CONDITIONS

Brief Title

Brain Cognitive Network Abnormalities in Anemia Patients Using fNIRS

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of anemia
  • First hospitalization
  • Male or female, aged 18 to 65 years
  • Willing and able to comply with the study requirements and provide written informed consent
Not Eligible

You will not qualify if you...

  • History of psychiatric illness
  • History of severe brain disease
  • Other reasons deemed unsuitable for inclusion by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Within 48 hours of admission

Participants undergo assessments including cognitive function, anxiety, depression, sleep quality, physical fatigue, appetite condition, and brain oxygenation using functional near-infrared spectroscopy within 48 hours of admission.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

Regenerative Medicine Center

Tianjin, Tianjin Municipality, China

Actively Recruiting

Loading map...

Research Team

Z

ZheXiang Kuang, MSN

X

Xiao Yu, Undergraduate

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Use of [F-18] FLT for Imaging With Positron Emission Tomogra...

Brain and Central Nervous System Tumors

Actively Recruiting

1 location

Proof-Of-Concept Study of Metabolically Optimized, Non-Cytot...

Myelodysplastic Syndromes

Actively Recruiting

1 location

A Multi-phase, Pharmacokinetics, Safety, and Efficacy Study ...

Myelodysplastic Syndromes

Actively Recruiting

71 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here